$295.71
+1.74
(+0.59%)▲
1.37%
Downside
Day's Volatility :1.64%
Upside
0.27%
27.87%
Downside
52 Weeks Volatility :59.54%
Upside
43.91%
Period | Humana Inc. | Sector (Health Care) | S&P500 |
---|---|---|---|
3 Months | -16.64% | -6.9% | 6.8% |
6 Months | -17.08% | -1.7% | 12.1% |
1 Year | -42.65% | 10.4% | 30.6% |
3 Years | -31.61% | 8.8% | 27.0% |
Market Capitalization | 35.4B |
Book Value | $145.88 |
Dividend Share | 3.54 |
Dividend Yield | 1.27% |
Earnings Per Share (EPS) | 11.47 |
PE Ratio | 25.63 |
PEG Ratio | 1.27 |
Wall Street Target Price | 288.15 |
Profit Margin | 1.18% |
Operating Margin TTM | 2.66% |
Return On Assets TTM | 4.01% |
Return On Equity TTM | 7.84% |
Revenue TTM | 115.0B |
Revenue Per Share TTM | 949.94 |
Quarterly Revenue Growth YOY | 11.3% |
Gross Profit TTM | 17.2B |
EBITDA | 3.8B |
Diluted Eps TTM | 11.47 |
Quarterly Earnings Growth YOY | -0.41 |
EPS Estimate Current Year | 16.14 |
EPS Estimate Next Year | 17.21 |
EPS Estimate Current Quarter | 3.4 |
EPS Estimate Next Quarter | -1.37 |
What analysts predicted
Downside of 2.56%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 56.9B | ↑ 5.85% |
Net Income | 1.7B | ↓ 31.25% |
Net Profit Margin | 2.96% | ↓ 1.59% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 64.9B | ↑ 14.01% |
Net Income | 2.7B | ↑ 60.84% |
Net Profit Margin | 4.17% | ↑ 1.21% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 77.2B | ↑ 18.9% |
Net Income | 3.4B | ↑ 24.38% |
Net Profit Margin | 4.36% | ↑ 0.19% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 83.1B | ↑ 7.66% |
Net Income | 2.9B | ↓ 12.89% |
Net Profit Margin | 3.53% | ↓ 0.83% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 92.9B | ↑ 11.81% |
Net Income | 2.8B | ↓ 4.33% |
Net Profit Margin | 3.02% | ↓ 0.51% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 106.4B | ↑ 14.54% |
Net Income | 2.5B | ↓ 11.3% |
Net Profit Margin | 2.34% | ↓ 0.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 26.7B | ↑ 0.02% |
Net Income | 959.0M | ↓ 22.6% |
Net Profit Margin | 3.59% | ↓ 1.04% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 26.4B | ↓ 1.21% |
Net Income | 832.0M | ↓ 13.24% |
Net Profit Margin | 3.15% | ↓ 0.44% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 26.5B | ↑ 0.15% |
Net Income | -541.0M | ↓ 165.02% |
Net Profit Margin | -2.04% | ↓ 5.19% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 29.6B | ↑ 11.9% |
Net Income | 741.0M | ↓ 236.97% |
Net Profit Margin | 2.5% | ↑ 4.54% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 29.5B | ↓ 0.24% |
Net Income | 679.0M | ↓ 8.37% |
Net Profit Margin | 2.3% | ↓ 0.2% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 29.4B | ↓ 0.48% |
Net Income | 480.0M | ↓ 29.31% |
Net Profit Margin | 1.63% | ↓ 0.67% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 25.4B | ↓ 6.49% |
Total Liabilities | 15.3B | ↓ 12.02% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 29.1B | ↑ 14.41% |
Total Liabilities | 17.0B | ↑ 11.7% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 35.0B | ↑ 20.28% |
Total Liabilities | 6.1B | ↓ 64.43% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 44.4B | ↑ 26.85% |
Total Liabilities | 10.5B | ↑ 73.94% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 43.1B | ↓ 2.94% |
Total Liabilities | 9.0B | ↓ 14.3% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 47.1B | ↑ 9.31% |
Total Liabilities | 30.7B | ↑ 240.35% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 56.5B | ↑ 3.07% |
Total Liabilities | 39.6B | ↑ 3.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 55.9B | ↓ 0.97% |
Total Liabilities | 9.5B | ↓ 76.03% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 47.1B | ↓ 15.81% |
Total Liabilities | 10.2B | ↑ 7.7% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 50.1B | ↑ 6.43% |
Total Liabilities | 12.4B | ↑ 21.32% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 50.1B | ↑ 0.0% |
Total Liabilities | 11.7B | ↓ 5.2% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 50.0B | ↓ 0.17% |
Total Liabilities | 32.4B | ↑ 175.69% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.2B | ↓ 46.36% |
Investing Cash Flow | -3.1B | ↑ 4.96% |
Financing Cash Flow | -785.0M | ↓ 16.93% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.3B | ↑ 143.17% |
Investing Cash Flow | -1.3B | ↓ 58.6% |
Financing Cash Flow | -2.3B | ↑ 192.36% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.6B | ↑ 6.72% |
Investing Cash Flow | -3.1B | ↑ 139.83% |
Financing Cash Flow | -2.0B | ↓ 14.81% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.3B | ↓ 59.89% |
Investing Cash Flow | -6.6B | ↑ 113.9% |
Financing Cash Flow | 3.0B | ↓ 254.22% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 4.6B | ↑ 102.79% |
Investing Cash Flow | -1.0B | ↓ 84.66% |
Financing Cash Flow | -1.9B | ↓ 163.48% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.2B | ↓ 52.5% |
Investing Cash Flow | -733.0M | ↓ 43.27% |
Financing Cash Flow | 36.0M | ↓ 98.9% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.3B | ↓ 60.58% |
Investing Cash Flow | -2.6B | ↑ 256.07% |
Financing Cash Flow | -1.7B | ↓ 4913.89% |
Sell
Neutral
Buy
Humana Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Humana Inc. | 12.73% | -17.08% | -42.65% | -31.61% | -12.57% |
The Cigna Corp | 3.97% | -1.9% | 14.48% | 56.02% | 63.52% |
Unitedhealth Group Incorporated | 4.85% | 14.6% | 9.88% | 36.56% | 115.83% |
Cvs Health Corporation | 0.44% | -0.59% | -17.41% | -38.6% | -24.18% |
Elevance Health, Inc | -3.87% | -26.32% | -15.91% | -3.77% | 38.3% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Humana Inc. | 25.63 | 25.63 | 1.27 | 16.14 | 0.08 | 0.04 | 0.01 | 145.88 |
The Cigna Corp | 30.68 | 30.68 | 0.77 | 28.5 | 0.08 | 0.03 | 0.02 | 150.61 |
Unitedhealth Group Incorporated | 39.07 | 39.07 | 1.63 | 27.61 | 0.15 | 0.07 | 0.01 | 102.42 |
Cvs Health Corporation | 14.42 | 14.42 | 1.96 | 5.37 | 0.07 | 0.02 | 0.05 | 59.57 |
Elevance Health, Inc | 14.47 | 14.47 | 0.74 | 33.02 | 0.16 | 0.06 | 0.02 | 188.74 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Humana Inc. | Buy | $35.4B | -12.57% | 25.63 | 1.18% |
The Cigna Corp | Buy | $90.0B | 63.52% | 30.68 | 1.32% |
Unitedhealth Group Incorporated | Buy | $552.6B | 115.83% | 39.07 | 3.64% |
Cvs Health Corporation | Buy | $71.5B | -24.18% | 14.42 | 1.37% |
Elevance Health, Inc | Buy | $92.2B | 38.3% | 14.47 | 3.69% |
Insights on Humana Inc.
Revenue is down for the last 3 quarters, 29.61B → 29.39B (in $), with an average decrease of 0.4% per quarter
Netprofit is down for the last 3 quarters, 741.0M → 480.0M (in $), with an average decrease of 18.8% per quarter
In the last 1 year, The Cigna Corp has given 14.5% return, outperforming this stock by 57.1%
In the last 3 years, The Cigna Corp has given 56.0% return, outperforming this stock by 87.6%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Dodge & Cox
Wellington Management Company LLP
Morgan Stanley - Brokerage Accounts
In the quarter ending March,2024. Humana Inc. has declared dividend of $0.89
Read Moreat humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.
Organization | Humana Inc. |
Employees | 67600 |
CEO | Ms. Susan Marie Diamond |
Industry | Health Services |
Xylem Inc.
$295.71
+0.59%
Cubesmart
$295.71
+0.59%
Banco De Chile
$295.71
+0.59%
Jpmorgan Usd Emerg Markets Bond Ishares
$295.71
+0.59%
Markel Group Inc
$295.71
+0.59%
Arcelormittal Sa
$295.71
+0.59%
Pnc Financial Services Group, Inc.
$295.71
+0.59%
Fair Isaac Corp
$295.71
+0.59%
Ge Healthcare Technologies Inc.
$295.71
+0.59%